Recombinant Candida glabrata COP9 signalosome complex subunit 5 (RRI1)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
RRI1; CSN5; CAGL0G05676gCOP9 signalosome complex subunit 5; EC 3.4.-.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-465
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (Yeast) (Torulopsis glabrata)
Target Names
RRI1
Target Protein Sequence
MDDFPSLNVS DLESKLLDYN IRDYEVQNSK HKNNIAGNEK ESIDQLSLLN QVCSLKNRKA IDSTKNSPLF YQNVLLSKLA CSKILCHATK GGNIEVMGML LGNVIGNTFV IFDCFELPVE GTETMVNAHM ESYEYMVQFY HEMVERSYTR NEENLNIIGW YHSHPGYDCW LSNIDMQTQS LNQQHQDPYL AIVVDPHKSK NDQKVRIGSF RTYQDQNDDT NFYELNTTVF DSELNKLENP LSVKIPFNSI ESRNLESNYL QKLSETVKQW RNFKIMEKIE NTAHTEDTTT NKSISTPGRI IQTAHEFAFA ATSNGNGSRV NIMRSNSVSS IGSSSDIEME DRNCSAFDSV ASSINTIADP SRTSSIHTQM NNQNNQQERN SPKRPHILPA IQSSRYGVIF EGKDRPENKN FNIRTASAQD AFESKCIDDF HESLKNDYLT QKEILLRLKL RQYYRLRMYR DMFSK
Uniprot No.

Target Background

Function
Catalytic component of the COP9 signalosome (CSN) complex. It regulates the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunit in SCF-type E3 ubiquitin-protein ligase complexes.
Database Links
Protein Families
Peptidase M67A family, CSN5 subfamily
Subcellular Location
Cytoplasm. Nucleus.

Q&A

Advanced Research Questions

  • What are the optimal methods for recombinant expression and purification of Candida glabrata RRI1?

    For successful recombinant expression of C. glabrata RRI1, researchers should consider a multi-faceted approach:

    a) Expression System Selection:

    • E. coli systems: BL21(DE3) or Rosetta strains for initial attempts

    • Yeast systems: S. cerevisiae or Pichia pastoris for proper folding and post-translational modifications

    • Insect cell systems: Consider for complex eukaryotic proteins with specific folding requirements

    b) Vector Design Considerations:

    • Include affinity tags (His6, GST, or MBP) for efficient purification

    • Codon optimization for the chosen expression host

    • Incorporate protease cleavage sites for tag removal

    c) Optimization Protocol:

    ParameterRecommended RangeNotes
    Temperature16-30°CLower temperatures often improve solubility
    Induction0.1-1.0 mM IPTG (bacterial)Optimize concentration
    MediaLB, TB, or defined mediaTest different formulations
    Co-expressionChaperones, CSN partnersMay improve folding/solubility

    d) Purification Strategy:

    • Multi-step approach combining affinity chromatography with size exclusion and/or ion exchange

    • Buffer optimization to maintain protein stability and activity

    • Activity assays to confirm functional protein isolation

    Based on molecular biology methods used for RRI1-related gene expression in C. glabrata, appropriate primers can be designed for cloning and expression vector construction .

  • How can the deneddylation activity of recombinant RRI1/CSN5 be effectively assessed?

    To assess the deneddylation activity of recombinant RRI1/CSN5, researchers can employ several complementary approaches:

    a) In vitro Deneddylation Assay:

    • Prepare neddylated cullins (Cdc53p/Cul1) as substrates

    • Incubate with purified recombinant RRI1/CSN5

    • Monitor deneddylation by western blotting using antibodies against the cullin and/or Rub1p/NEDD8

    • Include positive controls (human CSN) and negative controls (catalytically inactive mutants)

    b) Complementation Assays:

    • Use cell lysates from RRI1-deficient strains showing accumulated Rub1p-modified Cdc53p

    • Add recombinant RRI1/CSN5 and assess restoration of deneddylation activity

    • Wild-type cell lysate and purified human CSN can complement the deneddylation defect in vitro

    c) Analysis Protocol for Cullin Modification States:

    StepProcedureExpected Outcome
    1Prepare total cell lysates from wild-type and Δrri1 strainsTwo Cdc53p forms in wild-type, single modified form in mutant
    2Perform SDS-PAGE and immunoblottingVisualization of mobility shift
    3Add recombinant RRI1/CSN5 to mutant lysateRestoration of unmodified Cdc53p band
    4Quantify band intensity ratiosDetermination of deneddylation efficiency

    Wild-type cells display two forms of Cdc53p with different mobilities on SDS gels, while csn mutant strains accumulate Cdc53p exclusively in the Rub1p-modified form . This provides a clear readout for activity assessment.

  • What experimental models are most appropriate for studying RRI1's role in pathogenesis?

    For studying RRI1's role in C. glabrata pathogenesis, several experimental models can be employed:

    a) Galleria mellonella (Wax Moth) Larvae Model:

    • This model has been successfully used for C. glabrata virulence studies and provides several advantages :

      • Ethical considerations and cost-effectiveness

      • Can be maintained at 37°C (human physiological temperature)

      • Possesses an innate immune system with strong similarity to the mammalian system

    • Methodology: Standardized inoculum injection, survival rate monitoring, hemolymph recovery at different timepoints to quantify fungal burden

    b) Macrophage Interaction Assays:

    • C. glabrata can survive and replicate within macrophages for prolonged periods

    • Protocol parameters:

    ParameterDetailsMeasurements
    Cell typesJ774.A1, RAW264.7, primary macrophagesPhagocytosis rate, intracellular survival
    MOI1:1 to 10:1 (fungi:macrophage)Optimize based on experimental goals
    Time points1h, 24h, 48hMatch infection progression
    AnalysisMicroscopy, CFU counting, cytokine profilingMulti-parameter assessment

    c) Stress Response Assays:

    • Since RRI1 may affect stress responses like other virulence factors, assess:

      • Oxidative stress (H2O2, menadione)

      • Weak acid stress (acetic acid)

      • Nitrosative stress (NO donors)

    • Measure growth inhibition, gene expression changes, and protein modifications

  • How can genome editing approaches be utilized to study RRI1 function in Candida glabrata?

    Modern genome editing approaches offer powerful tools for studying RRI1 function:

    a) CRISPR-Cas9 System Adaptation for C. glabrata:

    • Design sgRNAs targeting RRI1 gene regions

    • Construct repair templates for precise modifications

    • Deliver components via transformation

    b) Targeted Modifications:

    Modification TypeApplicationAnalysis Method
    Complete gene deletionNull phenotypeCullin modification analysis
    Domain-specific mutationsStructure-functionBiochemical activity assays
    Promoter replacementConditional expressionqRT-PCR, western blotting
    Epitope taggingLocalization, interactionsImmunofluorescence, AP-MS

    c) Phenotypic Characterization Pipeline:

    • Growth under various conditions (temperature, pH, carbon sources)

    • Stress tolerance profiles (oxidative, osmotic, cell wall stressors)

    • Virulence factor expression and secretion

    • Host cell interaction assays

    d) Complementation Strategy:

    • Reintroduce wild-type or mutant RRI1 variants

    • Assess restoration of normal cullin modification patterns

    • Compare deneddylation activity in vitro and in vivo

  • How can contradictory data about RRI1 function be reconciled in experimental design?

    When facing contradictory data about RRI1 function, researchers should implement a systematic reconciliation approach:

    a) Strain and Condition Analysis:

    • Test RRI1 function across multiple C. glabrata strain backgrounds

    • Examine function under diverse conditions (media composition, temperature, pH)

    • Investigate genetic interaction context that might mask or reveal RRI1 functions

    b) Methodological Framework:

    ApproachImplementationBenefit
    Method diversificationUse complementary techniquesReduces method-specific artifacts
    Temporal resolutionTime-course experimentsCaptures dynamic processes
    Quantitative analysisStatistical rigor, replicationIncreases confidence in results
    Comprehensive controlsPositive/negative controlsValidates experimental system

    c) Reconciliation Strategies:

    • Perform epistasis analysis to position contradictory functions in pathways

    • Use conditional systems to separate temporal roles

    • Develop mathematical models to integrate seemingly contradictory data

    • Employ single-cell approaches to identify population heterogeneity effects

  • What techniques are most effective for studying protein-protein interactions of RRI1/CSN5?

    For comprehensive analysis of RRI1/CSN5 protein interactions:

    a) Affinity Purification-Mass Spectrometry (AP-MS):

    • Tandem affinity purification has successfully identified Rri1p/Csn5p-interacting proteins

    • TAP-tagging of RRI1/CSN5 followed by native condition purification

    • MS identification of co-purifying proteins

    • Quantitative approaches (SILAC, TMT labeling) to distinguish specific interactions

    b) Complementary Interaction Technologies:

    TechniqueApplicationStrengths
    Yeast Two-HybridBinary interaction screeningHigh throughput, in vivo
    BioID/TurboIDProximity-based labelingCaptures transient interactions
    Co-IPEndogenous complex isolationPreserves native interactions
    FRET/BiFCLive-cell visualizationSpatial and temporal resolution

    c) Network Analysis:

    • Integrate interaction data from multiple sources

    • Identify core complex components versus transient interactors

    • Map interaction changes under different conditions (stress, growth phase)

    • Compare with interaction networks from related species

  • What are the current challenges and future directions in studying the COP9 signalosome in pathogenic fungi?

    Current challenges and future research directions include:

    a) Structural and Compositional Challenges:

    • Limited homology between fungal and metazoan CSN subunits complicates comparative analysis

    • Uncertainty in assigning individual subunits to metazoan CSN1-8 counterparts

    • Need for improved structural biology approaches focused on fungal CSN complexes

    b) Research Frontiers:

    ChallengeApproachPotential Impact
    Functional redundancyCombinatorial gene deletionOvercome compensatory mechanisms
    Pathogenicity connectionsHost-pathogen interaction modelsIdentify virulence mechanisms
    Species variationComparative genomicsUniversal vs. species-specific functions
    Integration with other systemsMulti-omics approachesComprehensive pathway mapping

    c) Therapeutic Implications:

    • Identification of pathogen-specific aspects of CSN function

    • Development of selective inhibitors of fungal CSN activity

    • Validation of CSN components as potential drug targets

    • Design of combination strategies targeting CSN-dependent pathways

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.